# Seaport Therapeutics Inc. (SPTX)

Source: https://www.quantisnow.com/company/SPTX
Generated: 2026-11-10T11:09:13.256Z

- Ticker: SPTX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2026
- SEC CIK: 0002042347

## About

Seaport Therapeutics (Nasdaq: SPTX) is a clinical-stage therapeutics company focused on inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. Through its differentiated approach, the Company identifies clinically validated mechanisms with established efficacy and safety which had historically been limited by high first-pass metabolism, low bioavailability, and/or side effects. Seaport applies its proprietary Glyph platform to overcome those limitations and invent innovative oral therapies. With an experienced team of industry leaders, Seaport has a proven track record in neuropsychiatry drug discovery and development and delivering successful business outcomes. Seaport aims to develop novel, leading treatment options that will make a significant impact for patients and their families.

## Latest SPTX news and filings

- 2026-11-04 12:30 UTC [Insider Buy] [Director Torres Denice bought $99,325 worth of shares (5,000 units at $19.86) (SEC Form 4)](https://www.quantisnow.com/insight/director-torres-denice-bought-99325-worth-of-shares-5000-units-6771358)
- 2026-11-02 12:08 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Seaport Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-seaport-therapeutics-inc-6766060)
- 2026-11-02 12:03 UTC [SEC Form 8-K] [Seaport Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/seaport-therapeutics-inc-filed-sec-form-8-k-results-of-operations-6766044)
- 2026-11-02 12:00 UTC [Earnings] [Seaport Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress](https://www.quantisnow.com/insight/seaport-therapeutics-reports-third-quarter-2026-financial-results-and-highlights-6766011)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/SPTX
- Earnings history: https://www.quantisnow.com/earnings/SPTX
- Dividend history: https://www.quantisnow.com/dividends/SPTX
- Insider transactions: https://www.quantisnow.com/insiders/SPTX
- Options chain: https://www.quantisnow.com/options/SPTX
- SEC 8-K filings only: https://www.quantisnow.com/company/SPTX/8-k
- RSS and alerts for SPTX: https://www.quantisnow.com/docs/rss-feeds.md